Action Kidney Cancer
Share
Action Kidney Cancer is a patient led and managed national charity working directly with patients, carers and their families to provide everyone affected by kidney cancer with the best possible support, information and advocacy. Friendship...community...encouragement...advocacy...information...support...kindness...advice...shared experiences...patient stories...research news...expert insights...empowerment...
15/06/2026
The US Food and Drug Administration (FDA) has approved two medicines, belzutifan and pembrolizumab, for some patients with clear cell kidney cancer after kidney surgery (adjuvant therapy). The goal of adjuvant therapy is to help lower the chance of the cancer coming back after surgery.
This treatment combination (belzutifan plus pembrolizumab) is not currently available on the NHS as adjuvant therapy after surgery for kidney cancer. The appraisal of this combination is expected to start later in 2026, after which the decision about whether it can be used on the NHS will be made.
Read more on our website here:
FDA approves new adjuvant therapy for kidney cancer in the USA - Action Kidney Cancer The US Food and Drug Administration (FDA) has approved two medicines, belzutifan and pembrolizumab, for some patients with clear cell kidney cancer after kidney surgery (adjuvant therapy). The goal of adjuvant therapy is to help lower the chance of the cancer coming back after surgery. This treatmen...
Click here to claim your Sponsored Listing.
Category
Contact the organisation
Telephone
Address
Action Kidney Cancer, 11th Floor, 3 Piccadilly Place
Manchester
M13BN
Opening Hours
| Monday | 9am - 5pm |
| Tuesday | 9am - 5pm |
| Wednesday | 9am - 5pm |
| Thursday | 9am - 5pm |
| Friday | 9am - 5pm |
| Saturday | 9am - 12pm |
